Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Senate Republicans’ healthcare plans collapse

Senate Republicans' latest Affordable Care Act replacement plan was introduced on July 13. Four days later, it was declared dead, as four Republican senators had publicly announced they wouldn’t support even holding a vote on the legislation.

Thumbnail

Durbin: Some Republicans waiting on ACA repeal to fail to start bipartisan talks

U.S. Sen. Dick Durbin, D-Illinois, believes opponents of the Senate’s Better Care Reconciliation Act (BCRA) can use a delay in considering the bill to convince undecided Republicans to block it, particularly now that health insurers have come out strongly against the legislation.

Thumbnail

Hospitals remain opposed to Senate healthcare bill; AMA sees slight improvement

Whenever Republicans in the House or Senate have released a new version of an Affordable Care Act (ACA) replacement plan in 2017, healthcare industry reaction has been almost uniformly negative. The same can largely be said for the newest version of the Better Care Reconciliation Act (BCRA), with the notable exception of the American Medical Association (AMA) when it comes to two provisions. 

Thumbnail

New Senate healthcare bill allows insurance plans with fewer benefits, keeps Medicaid cuts

Senate Republicans have released a new version of their Affordable Care Act (ACA) replacement plan, adding new funding for stabilizing the individual market and keeping more of the ACA’s taxes, while also including a controversial proposal to allow insurance plans which don’t comply with ACA regulations on benefits and community rating.

Thumbnail

House passes FDA user fee reauthorization, Senate schedule unclear

The House has passed legislation to reauthorize user fee programs through the Food and Drug Administration (FDA) affecting medical devices, prescription and generic drugs.

Thumbnail

AHIP: Market instability, higher premiums for sicker enrollees under Cruz amendment

America’s Health Insurance Plans (AHIP), health insurers’ largest lobbying group, has been largely silent on Senate Republicans’ version on an Affordable Care Act (ACA) replacement plan, but now is warning against a conservative amendment to allow insurers to now offer plans which don’t comply with ACA regulations.

HHS approves Alaska reinsurance program to shore up ACA market

Alaska will receive $323 million from HHS from 2018 to 2022 for a reinsurance program to offset claims from high-cost patients for the lone insurer offering coverage on its Affordable Care Act exchange.

Senate delaying August recess to work on healthcare bill

Senate Majority Leader Mitch McConnell, R-Kentucky, has taken the unusual step of delaying the Senate’s August recess, announcing the chamber will stay in session during the first two weeks of the month to address legislative priorities like the replacement of the Affordable Care Act.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup